AI analyzes wearable data to reveal objective biomarkers for ADHD and anxiety, enabling passive tracking and earlier psychiatric detection.
Mark Gerstein, PhD
Advertisement
Articles by Mark Gerstein, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Psychiatric Times
1
New Positive Phase 2 Topline Data on Elunetirom for the Treatment of Bipolar Depression
2
Nonpharmacological Augmentation of Ketamine, Neuroplasticity, and Behavioral Therapy
3
Suicide Risk Assessment in Patients Denying Suicidal Intent
4
FDA Issues CRL for CTx-1301 for Treatment of ADHD
5